how to get glp-1 agonists Receptor as Treatments for Type 2 Diabetes History of glucagon-like peptide-1 receptor

The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: a real-world data analysis

10.1007/s00795-013-0053-9 [DOI] [PubMed] [Google Scholar] 163.Ohyama T, Sato K, Yamazaki Y, Hashizume H, Horiguchi N, Kakizaki S, et al

Need for Comprehensive Support: The findings highlight the growing interest in expanding GLP-1 use beyond weight loss to address complex health conditions, though providers emphasize the need for training and patient monitoring to support this shift

Humanas Q4 and recent partnerships : Humana saw its 2024 profit cut in half due to higher-than-expected medical costs in its Medicare Advantage plans

Novel GLP-1 mimetics in diabetes: lixisenatide and albiglutide

While the findings add to growing interest in the relationship between metabolic health, weight management, and reproductive function, the study authors advise caution and note that further research is necessary to investigate this association